作者: Jae-Hyung Chang , Vladimir Mushailov , Sumit Mohan , None
DOI: 10.1159/000095317
关键词: Internal medicine 、 Complication 、 Comorbidity 、 Artificial kidney 、 Medicine 、 Obesity 、 Epidemiology 、 Kidney transplantation 、 Nephrology 、 Intensive care medicine 、 Transplantation
摘要: Purpose of review Obesity has reached epidemic proportions in the United States. It is a risk factor for developing, among others, heart disease, stroke, type 2 diabetes, and chronic kidney disease (CKD), and thus a major public health concern and driver of healthcare costs. Although the prevalence of obesity in the CKD/end-stage kidney disease population is increasing, many obese patients are excluded from the benefit of kidney transplant based on their BMI alone. For this reason, we sought to review the experience thus far with kidney …